Omega Pharma (EBR:OME)

Reuters  Dec 16  Comment 
Sophia Genetics, a data-driven medicine company backed by British entrepreneur Mike Lynch, has raised $15 million of new funding from investors including Omega Pharma founder Marc Coucke to grow its genetic analysis platform.
Benzinga  Mar 30  Comment 
Perrigo Company plc Ordinary Shares (NYSE: PRGO) recently completed its acquisition of Omega Pharma Invest N.V. Perrigo CEO Joseph Papa was on CNBC Monday to discuss the benefits of the deal and Perrigo's move to Ireland. The...
Wall Street Journal  Nov 6  Comment 
Perrigo agreed to buy Belgium-based Omega Pharma in a deal valued at $4.5 billion as part of a bid to expand its portfolio of over-the-counter drugs and broaden its presence throughout Europe.
Benzinga  Oct 30  Comment 
Shares of Perrigo Company plc (NYSE: PRGO) surged higher Thursday amid reports that the company will buy Omega Pharma NV. Bloomberg reported that "Perrigo Co. has entered exclusive talks to buy Omega Pharma NV after beating suitors including...
Reuters  Oct 22  Comment 
Boehringer Ingelheim is not interested in taking over privately held Omega Pharma NV , a spokesman for the German drugmaker said on Wednesday.
FiercePharma  Oct 21  Comment 
Actavis seems to have a finger in every pie lately when it comes to pharma M&A, and rumor has it Omega Pharma's sales process is no exception.
FiercePharma  Jul 8  Comment 
Lately, OTC businesses have been selling like hotcakes, with a number of global consumer players looking to bulk up. Now, reports say Belgium's Omega Pharma could be the next to enter the deal arena with an OTC business worth more than $4 billion.
Reuters  Jul 8  Comment 
Omega Pharma NV [COUCKO.UL], a Belgian over-the-counter healthcare supplier, said any speculation about the future of the company was premature as no decision had yet been taken,...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki